OrbiMed’s Realm Therapeutics plc American Depositary Shares RLM Stock Holding History

OrbiMed’s Portfolio RLM Stock Details RLM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,021,484	Closed	-$2.87M	–	148
2019 Q2	$2.87M	Hold	1,021,484	–	–	0.04%	118
2019 Q1	$3.93M	Hold	1,021,484	–	–	0.06%	112
2018 Q4	$1.89M	Hold	1,021,484	–	–	0.03%	116
2018 Q3	$3.05M	Buy	+1,021,484	New	+$4.38M	0.04%	135

OrbiMed's RLM Position: Q3 2019 in Review

OrbiMed sold out of Realm Therapeutics plc American Depositary Shares (RLM) in Q3 2019, closing a stake of 1,021,484 shares — an estimated $2.87M sold.

OrbiMed first reported a position in RLM in Q3 2018 and held it in 4 quarters. The position peaked at $3.93M in Q1 2019. 0 funds tracked by Wall St. Rank hold RLM as of Q3 2019.

OrbiMed reported no remaining Realm Therapeutics plc American Depositary Shares position as of Q3 2019 after selling out during the quarter.
OrbiMed sold 1,021,484 Realm Therapeutics plc American Depositary Shares shares in Q3 2019, an estimated $2.87M.
OrbiMed first reported a position in Realm Therapeutics plc American Depositary Shares in Q3 2018 and held it in 4 quarters.
OrbiMed's Realm Therapeutics plc American Depositary Shares position peaked at $3.93M in Q1 2019.
0 funds tracked by Wall St. Rank held Realm Therapeutics plc American Depositary Shares as of Q3 2019.

Based on OrbiMed's 13F filing for Q3 2019, filed 14 Nov 2019.